Cargando…
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism
Neuroblastoma, a childhood cancer with highly heterogeneous biology and clinical behavior, is characterized by genomic aberrations including amplification of MYCN. Hemizygous deletion of chromosome 11q is a well-established, independent marker of poor prognosis. While 11q22-q23 is the most frequentl...
Autores principales: | Mandriota, Stefano J., Valentijn, Linda J., Lesne, Laurence, Betts, David R., Marino, Denis, Boudal-Khoshbeen, Mary, London, Wendy B., Rougemont, Anne-Laure, Attiyeh, Edward F., Maris, John M., Hogarty, Michael D., Koster, Jan, Molenaar, Jan J., Versteeg, Rogier, Ansari, Marc, Gumy-Pause, Fabienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621910/ https://www.ncbi.nlm.nih.gov/pubmed/26053094 |
Ejemplares similares
-
The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damage
por: Sappino, A-P, et al.
Publicado: (2012) -
PRIMA-1(MET)-induced neuroblastoma cell death is modulated by p53 and mycn through glutathione level
por: Mlakar, Vid, et al.
Publicado: (2019) -
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
por: Gamble, Laura D., et al.
Publicado: (2021) -
New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
por: Ricci, Anastasia, et al.
Publicado: (2022) -
Identification of ATM Mutations in Korean Siblings with Ataxia-Telangiectasia
por: Huh, Hee Jae, et al.
Publicado: (2013)